## SNPS: Synopsys, Inc. - XLK: Technology

### Executive Summary

No thesis match: MRS_10 0.8% below STRENGTH zone (3.0-6.0%); PEG 2.88 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($444.39)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bearish (Bullish: 1, Bearish: 9)

**1. Synopsys, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before December 30, 2025 to Discuss Your Rights - SNPS**
- Source: Morningstar | 20251223T140814 | Bearish | Relevance: 100%
- Levi & Korsinsky, LLP has filed a class action securities lawsuit against Synopsys, Inc. (NASDAQ: SNPS), alleging the company made false statements and concealed issues regarding its Design IP business and the impact of its focus on AI customers. Investors who suffered losses between December 4, 2024, and September 9, 2025, are encouraged to contact the firm before December 30, 2025, to discuss their rights and potential compensation without out-of-pocket costs.

**2. SNPS SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Synopsys, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!**
- Source: FOX 2 | 20251223T120831 | Bearish | Relevance: 100%
- Bronstein, Gewirtz & Grossman, LLC has announced a class action lawsuit against Synopsys, Inc. (NASDAQ:SNPS) on behalf of investors who purchased securities between December 4, 2024, and September 9, 2025. The lawsuit alleges that Synopsys and its officers made materially false and/or misleading statements regarding the impact of increased focus on AI customers on its Design IP business economics. Shareholders have until December 30, 2025, to request to be appointed lead plaintiff.

**3. SNPS STOCK: Synopsys, Inc. IP Underperformance Triggers Securities Fraud Class Action - Contact BFA Law by December 30 Court Deadline**
- Source: KLAS 8 News Now | 20251222T200828 | Bearish | Relevance: 100%
- A class action lawsuit has been filed against Synopsys, Inc. (NASDAQ:SNPS) and its executives for securities fraud following a significant stock drop. The lawsuit alleges that Synopsys misrepresented the financial stability of its Design IP segment, which was negatively impacted by increased customer demand for customization. Investors have until December 30, 2025, to seek appointment as lead plaintiff in the case.

**4. Deadline Alert: Synopsys, Inc. (SNPS) Shareholders Who Lost**
- Source: GlobeNewswire | 20251222T180907 | Bearish | Relevance: 100%
- Glancy Prongay & Murray LLP reminds Synopsys, Inc. (NASDAQ: SNPS) investors of the December 30, 2025, deadline to file as lead plaintiff in a class action lawsuit. This suit alleges that the company made misleading statements between December 4, 2024, and September 9, 2025, concerning its Design IP business, which underperformed expectations and led to a significant stock price drop. Investors who suffered losses are urged to contact the firm to pursue claims for recovery under federal securities laws.

**5. Deadline Alert: Synopsys, Inc. (SNPS) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit**
- Source: GlobeNewswire | 20251222T180031 | Bearish | Relevance: 100%
- Glancy Prongay & Murray LLP is alerting investors of Synopsys, Inc. (SNPS) to a December 30, 2025 deadline to file as lead plaintiff in a class action lawsuit. This lawsuit alleges that Synopsys made misleading statements regarding its business, operations, and prospects, leading to a significant stock price drop after the company reported disappointing Q3 2025 financial results and a decline in its Design IP segment. Investors who suffered losses between December 4, 2024, and September 9, 2025, are encouraged to contact the firm.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 6, Lowers: 5)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-12 | Morgan Stanley | $550 | $510 | +8% |
| 2025-12-11 | JP Morgan | $650 | $600 | +8% |
| 2025-12-11 | Wells Fargo | $500 | $445 | +12% |
| 2025-12-11 | Keybanc | $600 | $575 | +4% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-12 | Morgan Stanley | main | Overweight |
| 2025-12-11 | JP Morgan | main | Overweight |
| 2025-12-11 | Wells Fargo | main | Equal-Weight |
| 2025-12-11 | Keybanc | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 9 ($0.00M) |
| Sells | 4 ($0.06M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 40.5% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 9.8% (+20.7%)
- Blackrock Inc.: 8.2% (+18.5%)
- State Street Corpora: 4.7% (+20.6%)
- Capital World Invest: 4.0% (-3.7%)
- FMR, LLC: 3.1% (+47.5%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Analyst target momentum: 6 raises (avg +8%) could attract flows.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 2.88 signals overvaluation risk, limited margin of safety. Quality metrics strong (margin 19%). Analyst sentiment positive (6 raises, avg +8%). Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $91.0B |
| Beta | 1.15 |
| 52W Range | $365.74 - $651.73 |
| Short Interest | 2.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.88 |
| Forward P/E | 28.1 |
| Current P/E | 33.0 |
| YoY Growth | 17.7% |
| EPS Direction | STABLE |

### Technicals

MRS_10 stable at 0.8% (minimal 5-day change). Below STRENGTH zone by 2.2pp (needs >3.0% for momentum thesis). MRS_5 at 0.4% confirms short-term momentum alignment. Below SMA200 (0.97x), long-term trend not supportive. MACD histogram positive (1.70), confirming momentum. OFD pattern: -SLL (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 0.83% (CS: 83) | Neutral |
| RSI_14 | 61.7 | Neutral |
| MACD Histogram | 1.70 | Bullish |
| vs SMA20 | 1.045x | Above |
| vs SMA50 | 1.090x | Above |
| vs SMA200 | 0.972x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $475.47
- **Stop Loss:** $444.39 (6.5% risk)
- **Target:** $506.55 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 38
- **Position Value:** $18,067.86
- **Portfolio %:** 18.07%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 120% | L2 100% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite in holiday-thinned conditions. VIX at 52-week lows suggests complacency, but modest breadth improvement and stable yields indicate underlying stability. Focus on quality positioning ahead of 2026 catalysts.*

### Earnings

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $2.88 | $2.90 | +0.7% |
| 2025Q3 | $3.75 | $3.39 | -9.5% |
| 2025Q2 | $3.40 | $3.67 | +8.0% |
| 2025Q1 | $2.79 | $3.03 | +8.6% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_10*